These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 25251959)
21. Synergic Suppressive Effect of Silodosin and Imidafenacin on Non-Voiding Bladder Contractions in Male Rats with Subacute Bladder Outlet Obstruction. Sugiyama R; Aizawa N; Ito H; Fujimura T; Suzuki M; Nakagawa T; Fukuhara H; Kume H; Homma Y; Igawa Y Low Urin Tract Symptoms; 2017 May; 9(2):94-101. PubMed ID: 28394493 [TBL] [Abstract][Full Text] [Related]
22. Treatment satisfaction with tadalafil or tamsulosin vs placebo in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH): results from a randomised, placebo-controlled study. Oelke M; Giuliano F; Baygani SK; Melby T; Sontag A BJU Int; 2014 Oct; 114(4):568-75. PubMed ID: 24612148 [TBL] [Abstract][Full Text] [Related]
23. Effects of alpha 1-adrenergic receptor subtype selective antagonists on lower urinary tract function in rats with bladder outlet obstruction. Gu B; Reiter JP; Schwinn DA; Smith MP; Korstanje C; Thor KB; Dolber PC J Urol; 2004 Aug; 172(2):758-62. PubMed ID: 15247777 [TBL] [Abstract][Full Text] [Related]
24. Solifenacin plus tamsulosin combination treatment in men with lower urinary tract symptoms and bladder outlet obstruction: a randomized controlled trial. Kaplan SA; He W; Koltun WD; Cummings J; Schneider T; Fakhoury A Eur Urol; 2013 Jan; 63(1):158-65. PubMed ID: 22831853 [TBL] [Abstract][Full Text] [Related]
25. Effects of tamsulosin on bladder blood flow and bladder function in rats with bladder outlet obstruction. Okutsu H; Matsumoto S; Hanai T; Noguchi Y; Fujiyasu N; Ohtake A; Suzuki M; Sato S; Sasamata M; Uemura H; Kurita T Urology; 2010 Jan; 75(1):235-40. PubMed ID: 19647304 [TBL] [Abstract][Full Text] [Related]
26. Effect of co-administration of two different phosphodiesterase inhibitors and a β Linhares BL; Nascimento NRF; Gonzaga-Silva LF; Santos CF; Moraes MO; Marinho LB; Silva APG; Fonteles MC; Reges R Eur J Pharmacol; 2018 Aug; 833():425-431. PubMed ID: 29913125 [TBL] [Abstract][Full Text] [Related]
27. L-NAME, a nitric oxide synthase inhibitor, diminishes oxidative damage in urinary bladder partial outlet obstruction. Conners W; Whitebeck C; Chicester P; Legget R; Lin AD; Johnson A; Kogan B; Levin R; Mannikarottu A Am J Physiol Renal Physiol; 2006 Feb; 290(2):F357-63. PubMed ID: 16174866 [TBL] [Abstract][Full Text] [Related]
28. Presence of phosphodiesterase type 5 in the spinal cord and its involvement in bladder outflow obstruction related bladder overactivity. Füllhase C; Hennenberg M; Giese A; Schmidt M; Strittmatter F; Soler R; Gratzke C; Andersson KE; Stief C J Urol; 2013 Oct; 190(4):1430-5. PubMed ID: 23545097 [TBL] [Abstract][Full Text] [Related]
29. Urodynamic standardization in a large-scale, multicenter clinical trial examining the effects of daily tadalafil in men with lower urinary tract symptoms with or without benign prostatic obstruction. Kraus SR; Dmochowski R; Albo ME; Xu L; Klise SR; Roehrborn CG Neurourol Urodyn; 2010 Jun; 29(5):741-7. PubMed ID: 20151469 [TBL] [Abstract][Full Text] [Related]
30. The relaxant effect of ginseng saponin on the bladder and prostatic urethra: an in vitro and in vivo study. Jang HA; Cho S; Kang SG; Ko YH; Kang SH; Bae JH; Cheon J; Kim JJ; Lee JG Urol Int; 2012; 88(4):463-9. PubMed ID: 22507987 [TBL] [Abstract][Full Text] [Related]
31. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency. Simko F; Luptak I; Matuskova J; Babal P; Pechanova O; Bernatova I; Hulin I Ann N Y Acad Sci; 2002 Jun; 967():454-62. PubMed ID: 12079874 [TBL] [Abstract][Full Text] [Related]
32. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial. Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S J Urol; 2010 Mar; 183(3):1092-7. PubMed ID: 20092847 [TBL] [Abstract][Full Text] [Related]
33. Tamsulosin versus tamsulosin plus tadalafil as medical expulsive therapy for lower ureteric stones: a randomized controlled trial. Jayant K; Agrawal R; Agrawal S Int J Urol; 2014 Oct; 21(10):1012-5. PubMed ID: 24894533 [TBL] [Abstract][Full Text] [Related]
34. The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstruction. Kaiho Y; Nishiguchi J; Kwon DD; Chancellor MB; Arai Y; Snyder PB; Yoshimura N BJU Int; 2008 Mar; 101(5):615-20. PubMed ID: 18070178 [TBL] [Abstract][Full Text] [Related]
35. Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard? Silva J; Silva CM; Cruz F Curr Opin Urol; 2014 Jan; 24(1):21-8. PubMed ID: 24231531 [TBL] [Abstract][Full Text] [Related]
36. Increased contractile response to phenylephrine in detrusor of patients with bladder outlet obstruction: effect of the alpha1A and alpha1D-adrenergic receptor antagonist tamsulosin. Bouchelouche K; Andersen L; Alvarez S; Nordling J; Bouchelouche P J Urol; 2005 Feb; 173(2):657-61. PubMed ID: 15643283 [TBL] [Abstract][Full Text] [Related]
37. The effect of long-term oral tadalafil treatment on corpus cavernosum function in an experimental spinal cord transection rat model. Toksoz S; Erdem SR; Peskircioglu CL; Keskin U Spinal Cord; 2013 Sep; 51(9):663-7. PubMed ID: 23797570 [TBL] [Abstract][Full Text] [Related]
38. Effects of tadalafil once daily on maximum urinary flow rate in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Roehrborn CG; Chapple C; Oelke M; Cox D; Esler A; Viktrup L J Urol; 2014 Apr; 191(4):1045-50. PubMed ID: 24445278 [TBL] [Abstract][Full Text] [Related]
39. The effect of tamsulosin on the response of the rabbit bladder to partial outlet obstruction. Levin RM; Longhurst PA; Whitbeck C; Korstanje C Neurourol Urodyn; 2006; 25(1):89-94. PubMed ID: 16173041 [TBL] [Abstract][Full Text] [Related]
40. Hemodynamic interaction between a daily dosed phosphodiesterase 5 inhibitor, tadalafil, and the alpha-adrenergic blockers, doxazosin and tamsulosin, in middle-aged healthy male subjects. Guillaume M; Lonsdale F; Darstein C; Jimenez MC; Mitchell MI J Clin Pharmacol; 2007 Oct; 47(10):1303-10. PubMed ID: 17906163 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]